The Hydration Pharmaceuticals Co Ltd: Change of Registered Office Address
The Hydration Pharmaceuticals Co Ltd: Completion of divesture of non-US assets
The Hydration Pharmaceuticals Co Ltd: Divesture of Hydralyte's non-US assets
The Hydration Pharmaceuticals Co Ltd: Change of Directors Interest Notice
The Hydration Pharmaceuticals Co Ltd: Q2 FY24 Quarterly Activities Report (App 4C)
The Hydration Pharmaceuticals Co Ltd: Initial Director's Interest Notice
The Hydration Pharmaceuticals Co Ltd: Final Director's Interest Notice
The Hydration Pharmaceuticals Co Ltd: Issue of Shares
The Hydration Pharmaceuticals Co Ltd: Q1 FY24 Quarterly Activities Report (App 4C)
The Hydration Pharmaceuticals Co Ltd: Waiver of ASX Listing Rule 10.1 Granted
The Hydration Pharmaceuticals Co Ltd: Appendix 4G & Corporate Governance Statement
The Hydration Pharmaceuticals Co Ltd: Variation to Facility Agreement with PURE Asset Management
The Hydration Pharmaceuticals Co Ltd: Notification of AGM Date
The Hydration Pharmaceuticals Co Ltd: Q4 FY23 Quarterly Activities Report (App 4C)
The Hydration Pharmaceuticals Co Ltd: Upcoming Release of Securities from Escrow
The Hydration Pharmaceuticals Co Ltd: Notice of Upcoming Investor Webinar
The Hydration Pharmaceuticals Co Ltd: Q3 FY23 Quarterly Activities Report (App 4C)
The Hydration Pharmaceuticals Co Ltd: Response to ASX Query
The Hydration Pharmaceuticals Co Ltd: Change of Directors Interest Notice
The Hydration Pharmaceuticals Co Ltd: Final Directors Interest Notice
No Data
No Data